SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (453)4/30/2001 8:52:49 PM
From: scaram(o)uche  Read Replies (1) of 2243
 
Oh, man, that's ugly.

quote.yahoo.com

Went as low as 50% book. I don't know how to make ratios like that.

<g>

Any leverage in the business plan? As an example (homework not completed, particularly on "right to practice art" front), VGNX has both diagnostic and therapeutic (loss of heterozygosity) potential, and yet was sitting on 1:1 versus cash.

Any leverage? Looks like decent existing revenues.

"automated lipidic cubic phase (LCP) technology. With this technology, Emerald's crystallographers examine thousands of membrane protein crystallization experiments with small quantities of membrane protein."

Sounds sexy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext